NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that its first quarter 2019 revenues grew five percent year over year, driven by strong results across all of its business segments.

The company, headquartered in Waltham, Massachusetts, reported Q1revenues of $6.12 billion, up 5 percent from $5.85 billion during the same period last year, beating average expectations by Wall Street analysts of $6.02 billion. Organic revenue growth was 7 percent, acquisitions contributed 1 percent, and currency effects decreased revenue by 3 percent.